DCN and pancreatic neoplasm: These data strongly suggest that expressions levels of major ECM components, such as collagen I and III, are significantly decreased by DCN overexpression in HaP-T1 tumor tissues, thereby enhancing the therapeutic potential of RdB/IL12/DCN in overcoming the desmoplastic barrier of pancreatic tumors.